400 related articles for article (PubMed ID: 15032580)
21. Update on CD40 and CD154 blockade in transplant models.
Zhang T; Pierson RN; Azimzadeh AM
Immunotherapy; 2015; 7(8):899-911. PubMed ID: 26268734
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of CD86/CD28 and CD40/CD154 pathways in regulating monocyte-derived CD80 expression during their interaction with allogeneic endothelium.
Wang P; Liu Z; Wu C; Zhu B; Wang Y; Xu H
Transplant Proc; 2008 Oct; 40(8):2729-33. PubMed ID: 18929847
[TBL] [Abstract][Full Text] [Related]
23. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Li JM; Gorechlad J; Larsen CP; Waller EK
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
[TBL] [Abstract][Full Text] [Related]
24. The role of CD40 in the regulation of humoral and cell-mediated immunity.
Durie FH; Foy TM; Masters SR; Laman JD; Noelle RJ
Immunol Today; 1994 Sep; 15(9):406-11. PubMed ID: 7524518
[TBL] [Abstract][Full Text] [Related]
25. Critical role of lipid rafts in CD154-mediated T cell signaling.
El Fakhry Y; Alturaihi H; Diallo D; Merhi Y; Mourad W
Eur J Immunol; 2010 Mar; 40(3):770-9. PubMed ID: 20039299
[TBL] [Abstract][Full Text] [Related]
26. Estimation of the number of CD154 molecules in membrane extracts used as a source of CD40 stimulation of human B lymphocytes.
Ducas E; Dussault N; Roy A; Dumont N; Néron S
J Immunol Methods; 2009 May; 344(2):133-7. PubMed ID: 19332074
[TBL] [Abstract][Full Text] [Related]
27. The role of CD40 and CD154/CD40L in dendritic cells.
Ma DY; Clark EA
Semin Immunol; 2009 Oct; 21(5):265-72. PubMed ID: 19524453
[TBL] [Abstract][Full Text] [Related]
28. The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway.
Toubi E; Shoenfeld Y
Autoimmunity; 2004; 37(6-7):457-64. PubMed ID: 15621572
[TBL] [Abstract][Full Text] [Related]
29. Blockade of CD40-CD154 costimulatory pathway promotes survival of allogeneic corneal transplants.
Qian Y; Boisgerault F; Benichou G; Dana MR
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):987-94. PubMed ID: 11274076
[TBL] [Abstract][Full Text] [Related]
30. Immunotherapy targeting the CD40/CD154 costimulatory pathway for treatment of autoimmune disease.
Howard LM; Miller SD
Autoimmunity; 2004 Aug; 37(5):411-8. PubMed ID: 15621565
[TBL] [Abstract][Full Text] [Related]
31. CD40 and its ligand in the regulation of humoral immunity.
Klaus SJ; Berberich I; Shu G; Clark EA
Semin Immunol; 1994 Oct; 6(5):279-86. PubMed ID: 7532458
[TBL] [Abstract][Full Text] [Related]
32. CD154-CD40 interactions are essential for thymus-dependent antibody production in zebrafish: insights into the origin of costimulatory pathway in helper T cell-regulated adaptive immunity in early vertebrates.
Gong YF; Xiang LX; Shao JZ
J Immunol; 2009 Jun; 182(12):7749-62. PubMed ID: 19494299
[TBL] [Abstract][Full Text] [Related]
33. CD40-CD154 expression in calcified and non-calcified coronary lesions of patients with chronic renal failure.
Campean V; Neureiter D; Nonnast-Daniel B; Garlichs C; Gross ML; Amann K
Atherosclerosis; 2007 Jan; 190(1):156-66. PubMed ID: 16494885
[TBL] [Abstract][Full Text] [Related]
34. CD154 and its receptors in inflammatory vascular pathologies.
Hassan GS; Merhi Y; Mourad WM
Trends Immunol; 2009 Apr; 30(4):165-72. PubMed ID: 19282242
[TBL] [Abstract][Full Text] [Related]
35. Identification and isolation of murine antigen-reactive T cells according to CD154 expression.
Kirchhoff D; Frentsch M; Leclerk P; Bumann D; Rausch S; Hartmann S; Thiel A; Scheffold A
Eur J Immunol; 2007 Sep; 37(9):2370-7. PubMed ID: 17705136
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of CD23 hyperexpression on B cells from patients with rheumatoid arthritis.
De Miguel S; Galocha B; Jover JA; Bañares A; Hernández-García C; García-Asenjo JA; Fernández-Gutiérrez B
J Rheumatol; 2001 Jun; 28(6):1222-8. PubMed ID: 11409113
[TBL] [Abstract][Full Text] [Related]
37. The CD40-CD154 interaction in B cell-T cell liaisons.
Bishop GA; Hostager BS
Cytokine Growth Factor Rev; 2003; 14(3-4):297-309. PubMed ID: 12787567
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of pemphigus vulgaris by targeting of the CD40-CD154 co-stimulatory pathway: a step toward antigen-specific therapy?
Liu Z; Li N; Diaz LA
J Invest Dermatol; 2006 Jan; 126(1):11-3. PubMed ID: 16417211
[TBL] [Abstract][Full Text] [Related]
39. Activation-induced CD154 expression abrogates tolerance induced by apoptotic cells.
Gurung P; Kucaba TA; Ferguson TA; Griffith TS
J Immunol; 2009 Nov; 183(10):6114-23. PubMed ID: 19841180
[TBL] [Abstract][Full Text] [Related]
40. Failure of HIV-exposed CD4+ T cells to activate dendritic cells is reversed by restoration of CD40/CD154 interactions.
Zhang R; Lifson JD; Chougnet C
Blood; 2006 Mar; 107(5):1989-95. PubMed ID: 16269614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
